OMNIGEN RES LLC has a total of 35 patent applications. It decreased the IP activity by 20.0%. Its first patent ever was published in 2005. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets foods and drinks, pharmaceuticals and environmental technology are SHENZHEN HONGRUI BIOLOGICAL SCIENCE & TECH CO LTD, JUVENON INC and FUJIAN AONONG BIOLOGICAL TECH GROUP CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | EPO (European Patent Office) | 5 | |
#3 | WIPO (World Intellectual Property Organization) | 5 | |
#4 | Canada | 4 | |
#5 | China | 4 | |
#6 | Australia | 2 | |
#7 | Mexico | 2 | |
#8 | Argentina | 1 | |
#9 | Brazil | 1 | |
#10 | Chile | 1 | |
#11 | New Zealand | 1 | |
#12 | Philippines | 1 |
# | Industry | |
---|---|---|
#1 | Foods and drinks | |
#2 | Pharmaceuticals | |
#3 | Environmental technology | |
#4 | Machines |
# | Technology | |
---|---|---|
#1 | Fodder | |
#2 | Medical preparations | |
#3 | Climate change adaptation technologies | |
#4 | Enzymes | |
#5 | Therapeutic chemical compounds | |
#6 | Foods | |
#7 | Climate change mitigation in goods production | |
#8 | Special foods | |
#9 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Forsberg Neil E | 16 |
#2 | Puntenney Steven B | 14 |
#3 | Puntenney Steven Bruce | 9 |
#4 | Calabotta David | 9 |
#5 | Chapman James D | 9 |
#6 | Mclean Derek | 7 |
#7 | Forsberg Neil Elliott | 7 |
#8 | Costigan Tim | 6 |
#9 | Johnson A Bruce | 5 |
#10 | Rowson Angela D | 4 |
Publication | Filing date | Title |
---|---|---|
WO2020142305A1 | Feed supplements | |
US2019374622A1 | Composition and method for co-administration with a growth promotant | |
WO2019147799A1 | Bacillus combination for administration to animals | |
CN109688831A | Feed addictive comprising allicin | |
CA2997553A1 | A composition and/or combination for aquaculture | |
AU2011201420A1 | Beta-1,3(4)-endoglucanohydrolase, beta-1,3(4) glucan, diatomaceous earth, mineral clay and glucomannan to modulate gastrointestinal genes | |
NZ591978A | Beta-1, 3(4)-endoglucanohydrolase, beta-1,3(4) glucan, diatomaceous earth, mineral clay and glucomannan to modulate gastrointestinal genes | |
MX2008013619A | Augmentation of titer for vaccination in animals. | |
US2006239992A1 | Methods and compositions for the inhibition of growth of infectious Aspergillus fumigatus and other mycotic organisms in the gut of mammalian and avian species | |
EP1948237A1 | USE OF ß-1,3 (4)-ENDOGLUCANOHYDROLASE, ß-1,3 (4) GLUCAN, DIATOMACEOUS EARTH, MINERAL CLAY AND GLUCOMANNAN TO AUGMENT IMMUNE FUNCTION |